Rodolfo Milani
YOU?
Author Swipe
View article: Conservative Resolution of a Vesicovaginal Fistula Including Laser Therapy in a Patient Who Underwent Recurrent Surgery After Prior Radiotherapy for Endometrial Cancer
Conservative Resolution of a Vesicovaginal Fistula Including Laser Therapy in a Patient Who Underwent Recurrent Surgery After Prior Radiotherapy for Endometrial Cancer Open
Background Isolated vaginal vault recurrence of endometrial cancer can be treated with rescue radiotherapy. However, in previously irradiated patients, surgical resection can be considered the treatment of choice. Vesicovaginal fistulas (V…
View article: Supplemental Material Section S2 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S2 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 126K, Survival analysis methodology and results for each histotype.
View article: Supplemental Material Section S8 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S8 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 127K, miR-192 and miR-194 expression values stratified according to tumor grade and survival analysis (OS and PFS). Data shown refers to the entire cohort of 67 stage I mucinous EOC patients.
View article: Supplemental Material Section S6 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S6 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 217K, The clinical stratification of the 76 selected patients used for the integrative analysis and the MAGIA2 complete results.
View article: Data from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Data from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
Purpose: Epithelial ovarian cancer (EOC) is one of the most lethal gynecologic diseases, with survival rate virtually unchanged for the past 30 years. EOC comprises different histotypes with molecular and clinical heterogeneity, but…
View article: Supplemental Material Section S8 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S8 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 127K, miR-192 and miR-194 expression values stratified according to tumor grade and survival analysis (OS and PFS). Data shown refers to the entire cohort of 67 stage I mucinous EOC patients.
View article: Supplemental Material Section S3 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S3 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 162K, Human Ovarian Surface Epithelium (HOSE) experiments and analyses.
View article: Supplemental Material Section S7 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S7 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 330K, The clinical stratification of the 76 selected patients used for the integrative analysis and the MAGIA2 complete results.
View article: Supplemental Material Section S5 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S5 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 144K, Resampling strategy to identify miRNA markers.
View article: Supplemental Material Section S5 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S5 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 144K, Resampling strategy to identify miRNA markers.
View article: Supplemental Material Section S3 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S3 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 162K, Human Ovarian Surface Epithelium (HOSE) experiments and analyses.
View article: Data from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Data from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
Purpose: Epithelial ovarian cancer (EOC) is one of the most lethal gynecologic diseases, with survival rate virtually unchanged for the past 30 years. EOC comprises different histotypes with molecular and clinical heterogeneity, but…
View article: Supplemental Material Section S1 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S1 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 78K, Tissue sample collection.
View article: Supplemental Material Section S4 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S4 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 176K, miRNA expression analysis methodology, the complete lists of differentially expressed genes for each subtype comparison and the relative resampling score.
View article: Supplemental Material Section S7 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S7 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 330K, The clinical stratification of the 76 selected patients used for the integrative analysis and the MAGIA2 complete results.
View article: Supplemental Material Section S4 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S4 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 176K, miRNA expression analysis methodology, the complete lists of differentially expressed genes for each subtype comparison and the relative resampling score.
View article: Supplemental Material Section S6 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S6 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 217K, The clinical stratification of the 76 selected patients used for the integrative analysis and the MAGIA2 complete results.
View article: Supplemental Material Section S1 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S1 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 78K, Tissue sample collection.
View article: Supplemental Material Section S2 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Supplemental Material Section S2 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities Open
PDF file - 126K, Survival analysis methodology and results for each histotype.
View article: Supplementary Figure 1 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Supplementary Figure 1 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations Open
Supplementary Figure 1. Histologic characteristics of the original patient tumors and corresponding EOC-xenografts.
View article: Supplementary Tables 1 through 6 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Supplementary Tables 1 through 6 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations Open
Supplementary Table 1.Primers used for PCR amplification and sequencing Table 2. Clinico-pathological characteristics of the patients from which tumor specimens were trasplanted in nude mice. Table 3.Correlation analysis between engrafted …
View article: Supplementary Tables 1 through 6 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Supplementary Tables 1 through 6 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations Open
Supplementary Table 1.Primers used for PCR amplification and sequencing Table 2. Clinico-pathological characteristics of the patients from which tumor specimens were trasplanted in nude mice. Table 3.Correlation analysis between engrafted …
View article: Data from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Data from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations Open
Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy. On the basis of its histopathology and molecular-genomic changes, ovarian cancer has been divided into subtypes, each with distinct biology and outcome. The aim of …
View article: Supplementary Figure 4 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Supplementary Figure 4 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations Open
Supplementary Figure 4. Gene copy number in patient and xenograft
View article: Supplementary Figure 2 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Supplementary Figure 2 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations Open
Supplementary Figure 2. Comparative immuno-histologic analysis of patient tumor and the corresponding xenograft.
View article: Supplementary Figure 3 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Supplementary Figure 3 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations Open
Supplementary Figure 3. Comparative immunohistochemical analysis of xenografts at different passages.
View article: Supplementary Figure 5 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Supplementary Figure 5 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations Open
Supplementary Figure 5. Pearson's correlation coefficient across all EOCs.
View article: Supplementary Information from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Supplementary Information from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations Open
Supplementary Information
View article: Supplementary Figure 4 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Supplementary Figure 4 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations Open
Supplementary Figure 4. Gene copy number in patient and xenograft
View article: Supplementary Information from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Supplementary Information from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations Open
Supplementary Information